Clinical Trial

Long-Term Outcomes in SLE at Peking University People's Hospital

Study acronym: LOTUS
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to prospectively follow patients diagnosed with Systemic Lupus Erythematosus (SLE) at Peking University People's Hospital, assessing long-term outcomes such as disease activity, organ involvement, survival, and quality of life. Findings will support individualized patient management and contribute to understanding disease progression in the Chinese population.
Trial Details
NCT Number NCT07005479
Lead Sponsor Peking University People's Hospital
Conditions Systemic Lupus Erythematosus
Enrollment 1,000 participants
Start Date 2020-05-21
Primary Completion 2030-05-20 (estimated)
Study Completion 2032-05-20 (estimated)
Updated on ClinicalTrials.gov 2025-06-05